Advertisement

Reactions Weekly

, Volume 1734, Issue 1, pp 80–80 | Cite as

Bee-venom-allergy-immunotherapy/wasp-venom-allergy-immunotherapy

Various toxicites: 7 case reports
Case report
  • 21 Downloads

In a retrospective chart review of 78 patients, seven patients (six male and one female; aged 7−14 years) were described, who developed throat itching (2 patient), hives (2 patient), cough (1 patient), erythematous conjunctiva (1 patient) and vomiting and throat discomfort (1 patient) during treatment with bee-venom-allergy-immunotherapy [honeybee-venom-allergy immunotherapy], wasp-venom-allergy-immunotherapy [Polistes] or unspecified mixed vespids for treatment of hymenoptera insect sting [routes and outcomes not stated].

Patient 1: A 13-year-old girl developed throat itching during treatment with wasp-venom allergy immunotherapy and unspecified mixed vespids. The girl received wasp venom allergy immunotherapy and unspecified mixed vespids at a cumulative dose of 5µg during up-dosing phase for treatment of hymenoptera insect sting. She developed moderate throat itching (grade 1) in less than 30 minutes after wasp venom allergy immunotherapy administration. She received treatment with...

Reference

  1. Albuhairi S, et al. A twenty-two-year experience with Hymenoptera venom immunotherapy in a US pediatric tertiary care center 1996-2018. Annals of Allergy, Asthma and Immunology 121: 722-728 e1, No. 6, Dec 2018. Available from: URL: http://doi.org/10.1016/j.anai.2018.08.002 - USACrossRefPubMedGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Personalised recommendations